Works matching IS 02536269 AND DT 2025 AND VI 48 AND IP 2
Results: 5
A novel 11β-HSD1 inhibitor ameliorates liver fibrosis by inhibiting the notch signaling pathway and increasing NK cell population: 11β-HSD1 inhibitor ameliorates liver fibrosis: J. E. Kim et al.
- Published in:
- Archives of Pharmacal Research, 2025, v. 48, n. 2, p. 166, doi. 10.1007/s12272-025-01534-4
- By:
- Publication type:
- Article
Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors with promising anti-melanoma activity: rational design, synthesis, in vitro and in silico screening: Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors: A. Elkamhawy et al
- Published in:
- Archives of Pharmacal Research, 2025, v. 48, n. 2, p. 150, doi. 10.1007/s12272-025-01533-5
- By:
- Publication type:
- Article
Tumor microenvironment regulation by reactive oxygen species-mediated inflammasome activation: TME regulation by ROS-mediated inflammasome: J.-H. Jang et al.
- Published in:
- Archives of Pharmacal Research, 2025, v. 48, n. 2, p. 115, doi. 10.1007/s12272-025-01532-6
- By:
- Publication type:
- Article
Retraction Note: MiR-338-5p ameliorates pathological cardiac hypertrophy by targeting CAMKIIδ.
- Published in:
- Archives of Pharmacal Research, 2025, v. 48, n. 2, p. 181, doi. 10.1007/s12272-024-01530-0
- By:
- Publication type:
- Article
Immunosenescence and age-related immune cells: causes of age-related diseases.
- Published in:
- Archives of Pharmacal Research, 2025, v. 48, n. 2, p. 132, doi. 10.1007/s12272-024-01529-7
- By:
- Publication type:
- Article